Clinical & Translational Genomics | GenomeWeb

Clinical & Translational

Assessments of the firm's rapid molecular BRAF and EGFR tests by researchers in Italy and South Korea showed high sensitivity and a fast turnaround time.

A University of Toronto team developed the probes to improve upon its previously described electrochemical clamp assay technology.

The company recently closed a $7 million funding round and added to its executive team as it aims for a 2017 launch for its test.

Industry executives said they believe ASRs are key components for laboratory directors who need to quickly develop critical diagnostic tests. 

The company's diagnostic is being used to determine the eligibility of patients with solid tumors to participate in a Phase II trial of entrectinib.

In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.

A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.